NASDAQ:AGRX - Agile Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.56 -0.02 (-1.27 %)
(As of 03/22/2019 04:26 AM ET)
Previous Close$1.58
Today's Range$1.50 - $1.58
52-Week Range$0.23 - $3.01
Volume313,000 shs
Average Volume605,473 shs
Market Capitalization$67.41 million
P/E Ratio-2.69
Dividend YieldN/A

Analyst Ratings

Agile Therapeutics (NASDAQ:AGRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Agile Therapeutics in the last 12 months. Their average twelve-month price target is $3.3333, suggesting that the stock has a possible upside of 113.68%. The high price target for AGRX is $4.00 and the low price target for AGRX is $3.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.3333$3.3333$3.75$4.00
Price Target Upside: 113.68% upside266.30% upside362.96% upside479.71% upside

Agile Therapeutics (NASDAQ:AGRX) Consensus Price Target History

Price Target History for Agile Therapeutics (NASDAQ:AGRX)

Agile Therapeutics (NASDAQ:AGRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2019Maxim GroupReiterated RatingBuy$3.00HighView Rating Details
1/11/2019HC WainwrightReiterated RatingBuy$4.00MediumView Rating Details
5/21/2018Royal Bank of CanadaLower Price TargetOutperform$3.00HighView Rating Details
3/14/2018Noble FinancialReiterated RatingBuyHighView Rating Details
12/28/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLowView Rating Details
12/26/2017William BlairDowngradeOutperform ➝ Market PerformHighView Rating Details
12/22/2017Cantor FitzgeraldReiterated RatingBuy$5.00HighView Rating Details
(Data available from 3/22/2017 forward)
This page was last updated on 3/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel